Companies / Elevance Health Inc

Elevance Health Inc

NYSE: ELVCIK 1156039Health CareINDIANAPOLIS, INelevancehealth.com ↗

Financials · FY2025

Revenue$199.13B
Net income$5.66B
Total debt$31.04B
Cash$10.23B
Diluted EPS$25.21
Shares outstanding216.9M

Ownership

216.9M shares outstanding · as of Jul 10, 2026
0.17%Insiders
Ownership
Insiders0.17%375,252
10%+ / strategic7.65%16,601,224
Institutions93.79%203,396,428
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 19

View all →
Insider% of sharesShares
Boudreaux GailCEOPresident and CEO · Director
0.08%169,251
Norwood Felicia FEVP &Chief Health Benefits Ofr
0.02%38,838
Kaye MarkEVP & CFO
0.01%32,037
Haytaian Peter DEVP & Pres Carelon & CarelonRx
0.01%27,222
Lavu RatnakarEVP & Chief Digital Info Ofr
<0.01%16,149
Hay Lewis IIIDirector
<0.01%12,070
Kendrick Charles Morgan JREVP & President, Commercial
<0.01%11,791
Dixon Robert L JRDirector
<0.01%10,734
Peru Ramiro GDirector
<0.01%9,908
Wessling Erin MEVP & Chief Legal Officer
<0.01%7,579

Institutional holders 1,568

View all →
HolderValue% of shares
Vanguard Group Inc$8.07B10.61%
BlackRock, Inc.$7.34B8.76%
State Street Corporation$4.03B4.81%
Wellington Management Group LLP$2.91B3.82%
Sanders Capital, LLC$2.02B2.65%
Artisan Partners Asset Management Inc.$1.76B2.32%
Harris Associates L P$1.68B2.21%
Geode Capital Management, LLC$1.51B2.39%
Invesco Ltd.$1.37B1.80%
First Eagle Investment Management, LLC$1.21B1.91%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Norges Bank
13F manager
Exit—$-1.06B-3.0M
-100.00%
—
high
Q2 2026
as of
BlackRock, Inc.
13F manager
Trim—$-545.89M-1.4M
-6.92%
18,991,090
8.76% of shares
high
Q1 2026
as of
Amundi
13F manager
Add—$467.67M+1.6M
+145.73%
2,693,664
1.24% of shares
high
Q1 2026
as of
BAILLIE GIFFORD &amp; CO
13F manager
Trim—$-235.69M-805K
-40.70%
1,172,808
0.54% of shares
high
Q2 2023
as of
Barclays PLC
13F manager
Add—$194.25M+437K
+52.92%
1,263,401
0.58% of shares
high
Q3 2024
as of
Barclays PLC
13F manager
Trim—$-191.64M-369K
-37.24%
621,084
0.29% of shares
high
Q1 2026
as of
Grantham, Mayo, Van Otterloo &amp; Co. LLC
13F manager
Trim—$-172.60M-593K
-23.42%
1,938,276
0.89% of shares
high
Q1 2026
as of
Eminence Capital, LP
13F manager
Exit—$-170.77M-487K
-100.00%
—
high

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Vanguard Capital ManagementPassive13G—16,601,224—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ELV——036752103—